Today's Rundown Featured Story | | | Tuesday, April 14, 2020 Philips is rolling out a new emergency-use ventilator to help relieve some of the burden on intensive care units as well as to provide care both inside and outside of hospitals. |
|
|---|
|
Top Stories Tuesday, April 14, 2020 The survey found practices have seen an average 60% drop in patient volume on average and a 55% decrease in revenue since the beginning of the public health crisis. Tuesday, April 14, 2020 The COVID-19 pandemic is “one of the most significant events any of us have ever experienced,” J&J CEO Alex Gorsky said Tuesday. From there, execs revealed a multibillion-dollar guidance cut and outlined plans for the rest of 2020, offering some hints to what we'll see from pharma as Q1 results roll out. Tuesday, April 14, 2020 Sanofi and GlaxoSmithKline, two of the world’s biggest vaccine players, may be competitors, but the COVID-19 pandemic has now made them partners. The pharma giants are teaming up to develop a coronavirus shot—and to scale up manufacturing lickety-split. Tuesday, April 14, 2020 A phase 1 trial of Moderna’s COVID-19 vaccine candidate has begun enrolling subjects at the highest dose. Moderna shared the update on the COVID-19 study alongside news that people in another trial had anti-Zika antibodies after receiving the biotech’s vaccine against that virus. Tuesday, April 14, 2020 NIAID director Anthony Fauci said he believes a goal of reopening the U.S. on May 1 is "a bit overly optimistic." Former FDA chief Scott Gottlieb detailed the process needed as he sees it to reopen the country. Tuesday, April 14, 2020 FierceHealthcare's ongoing coverage of how the coronavirus is impacting the healthcare industry. Monday, April 13, 2020 Social distancing is critical in managing the spread of COVID-19, but it poses a major barrier to managing diabetes. Monday, April 13, 2020 Clinical genomics researchers at Rutgers University have received the FDA’s first emergency authorization for a COVID-19 diagnostic test that uses easy-to-collect saliva samples instead of the more difficult deep nose swabs. Tuesday, April 14, 2020 Software startup Clara Health built a registry platform and database to connect COVID-positive and -negative individuals with clinical trials. The goal is to more efficiently match volunteers with clinical trials and accelerate research timelines for COVID-19 treatments, therapies and vaccines. Tuesday, April 14, 2020 It’s a pretty grim story in Alzheimer’s research, with years of flops and setbacks against the memory-wasting disease. Tuesday, April 14, 2020 Add another drugmaker that’s repurposing existing med for COVID-19. AstraZeneca is now kicking off a clinical trial testing BTK inhibitor Calquence to help control dangerous immune complications in serious patients after researchers at the NIH's National Cancer Institute observed “some clinical benefit.” Tuesday, April 14, 2020 America's Essential Hospitals pressed Congress for direct funding to safety net hospitals to combat COVID-19, but also called for a series of policy and regulatory changes to Medicaid and 340B. Tuesday, April 14, 2020 What will it take to develop a vaccine for COVID-19? Johnson & Johnson is taking viewers behind the scenes with an original online video series. Beginning Tuesday, producer and journalist Lisa Ling will host a program titled, “The Road to a Vaccine." Each 30-minute show will air live online on Tuesdays on Facebook, Twitter, LinkedIn and JNJ.com. Tuesday, April 14, 2020 U.S. eyes have turned abroad as the coronavirus crisis raises concerns about the safety of the global supply chain. In moves that could shore up confidence, the FDA has given a run of overseas generics plants the all-clear to produce. |
|
